![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 28, 21416-21421, July 14, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the
Received for publication, March 23, 2000
The mechanisms of UVB-induced apoptosis and the
role of p38 mitogen-activated protein kinase (MAPK) were investigated
in HaCaT cells. UVB doses that induced apoptosis also produced a
sustained activation of p38 MAPK and mitochondrial cytochrome
c release, leading to pro-caspase-3 activation. Late into
the apoptotic process, UVB also induced a caspase-mediated cleavage
of Bid. Caspase inhibitors benzyloxycarbonyl-Val-Ala-Asp-fluoromethylketone and
benzyloxycarbonyl-Asp-Glu-Val-Asp-fluoromethylketone substantially
blocked the UVB-induced apoptosis without preventing the release
of mitochondrial cytochrome c and the p38 MAPK activation. The inhibition of p38 MAPK counteracted both apoptosis and cytochrome c release as well as the DEVD-amino-4-methylcoumarin
cleavage activity without affecting the processing of pro-caspase-8.
These results indicate that UVB induces multiple and independent
apoptotic pathways, which culminate in pro-caspase-3 activation, and
that the initial cytochrome c release is independent of
caspase activity. Importantly, we show that a sustained p38 MAPK
activation contributes to the UVB-induced apoptosis by mediating the
release of mitochondrial cytochrome c into the cytosol.
Ultraviolet (UV) radiation is the most important environmental
factor involved in the etiology of non-melanoma skin cancer (1). The
carcinogenic effects of the solar radiation have been mainly attributed
to the UVB (280-320 nm) fraction, while the potentially dangerous UVC
(100-290 nm) radiations are absorbed by the ozone layer and are
therefore not of physiological importance (2). Exposure of
keratinocytes to UVB leads to the expression of several genes involved
in cell cycle arrest, DNA repair, and/or apoptosis, an event that is
collectively known as the UV response (3). The induction of apoptosis
following UV irradiation is thought to be a protective mechanism
ensuring the removal of irreversibly damaged and potentially cancerous
cells, and recent reports indicate that both nuclear and cytosolic
events contribute critically to the overall apoptotic response (4).
Therefore, the decision whether epidermal keratinocytes undergo
apoptosis or not upon UV irradiation is a crucial process in photocarcinogenesis.
Recent studies have revealed that the basic mechanism of apoptosis
induced by UVB irradiation involves the typical process in which
caspases play a critical role (4-7). In addition, a number of reports
have established that the cell surface death receptors, namely
TNF1 receptor and Fas, are
clustered in a ligand-independent manner to initiate the process of
UV-induced apoptosis (6, 8-10). It is well recognized that the
clustering and activation of the Fas or TNF receptor leads to the
recruitment and subsequent activation of pro-caspase-8 via the adapter
molecule FADD (for Fas-associated death domain protein) (11). In this
so-called extrinsic pathway of caspase activation, caspase-8 leads to
the proteolytic activation of downstream effector caspases, cleavage of
vital protein substrates and subsequent apoptotic cell death.
Accordingly, UVB-induced apoptosis in keratinocytes has been shown to
be significantly counteracted by inhibitors of the initiator caspase-8
such as cytokine response modifier A and zVAD-fmk, or by the expression of dominant negative FADD (6, 10).
On the other hand, the intrinsic pathway for caspase activation,
induced by many apoptogenic stimuli, involves the mitochondrial release
of cytochrome c into the cytosol, which then acts as a trigger for the formation of a complex including the Apaf-1 (apoptotic protease-activating factor 1) and pro-caspase-9. This event culminates in the activation of pro-caspase-9, which can directly cleave and
activate the effector caspases, such as caspase-3, resulting in the
orchestration of the biochemical execution of the cell (12). In the
Fas- and/or TNF-mediated apoptosis, a cytochrome c-dependent mechanism of caspase activation can
also amplify the effect of caspase-8 on downstream caspases. In this
case, active caspase-8 cleaves Bid, a pro-apoptotic Bcl-2-interacting
protein, producing an active C-terminal fragment, which binds to
mitochondria and induces the release of cytochrome c (13).
In many cases, however, the mitochondrial release of cytochrome
c proceeds independently of caspase activity (14). An
important and still open question is whether this mitochondria-mediated
pathway of caspase activation is relevant to the overall UVB-induced
apoptotic response.
UV irradiation has been shown to result in the activation of several
members of the MAPK superfamily, comprising ERKs, JNKs, and p38 MAPK
(15-19). However, depending on the UV wavelengths and the type of
cells used, different regulatory effects by JNKs and ERKs on programmed
cell death have been described (16-19). In human keratinocytes, the
UVB-induced ERK activation was recently shown to be a protective signal
against apoptosis (19), whereas the activation of the p38 MAPK cascade
was reported to play a causative role in UVB-induced apoptosis (7).
However, how p38 MAPK interacts with the apoptotic machinery and the
caspase activation pathways during UVB-induced apoptosis is not yet established.
In this study, we show that in UVB-irradiated HaCaT cells, two
independent pathways of caspase activation and apoptosis are induced: a
caspase-8- and a cytochrome c-dependent pathway,
both of which converge on the activation of pro-caspase-3. Importantly, we show that the p38 MAPK pathway mediates apoptosis following UVB
irradiation by inducing the release of mitochondrial cytochrome c into the cytosol, which is followed by pro-caspase-3
activation. Furthermore, our results suggest that, in the late phase of
the apoptotic process, a caspase-8-dependent cleavage of
Bid may provide a mechanism to exacerbate cell death following UVB irradiation.
Materials--
Hoechst 33342 (bis-benzimide) was purchased from
Sigma. [ Cell Lines, Culture Conditions, and UVB Irradiation--
The
spontaneously immortalized human keratinocyte cell line HaCaT were
maintained in Dulbecco's modified Eagle's medium supplemented with
10% fetal calf serum, 2 mM L-glutamine, and
1% penicillin/streptomycin solution (all cell culture media and
supplements were purchased from Life Technologies, Inc.). Cells were
incubated in a 37 °C humidified air environment containing 5%
CO2. UVB irradiation was performed exactly as described
previously (15). All the drugs used in this study were added to culture
medium prior to treatment for the period of time indicated in figure legends.
Evaluation of Apoptosis and Caspase Activity--
Apoptosis was
evaluated either by fluorescent microscopic analysis of fragmented
nuclei stained with Hoechst 33342 or by light microscopy. Caspase
activity assays were performed as described in Ref. 20.
Preparation of Cell Extract and Western Blot
Analysis--
Preparation of cell extracts and Western blot analysis
were performed as described in Ref. 20.
Cell Proliferation Assay--
Cells (1 × 105
cells/plate) were seeded onto 6-cm2 plates. The caspase
inhibitor zVAD-fmk and the p38 MAPK inhibitor PD169316 were added 2 and
1 h, respectively, before irradiation, and zVAD-fmk was re-added
every 24 h. At each time point, cell proliferation was determined
by quantification of the cellular protein content using naphthol blue
black (Acros, Beerse, Belgium) as described in Ref. 21.
UVB Irradiation Induces p38 MAPK Activation and Apoptosis in HaCaT
Cells--
We initially examined the pattern of p38 MAPK activation in
HaCaT cells following UVB irradiation. A dose of 60 mJ/cm2
UVB irradiation resulted in a remarkable and sustained activation of
p38 MAPK (Fig. 1A), which was
observed with doses as low as 10 mJ/cm2 (data not shown).
No difference in the p38 MAPK protein level was observed in these
experiments (data not shown), indicating that the kinase activity
changes induced by UVB irradiation were due to post-translational
modifications of pre-existing enzyme molecules. Irradiation of HaCaT
cells with similar UVB doses resulted in the characteristic
morphological features of cells undergoing apoptosis; cells appeared
shrunk and apoptotic bodies were clearly visible (Fig. 1B,
b). Fluorescent microscopic analysis with Hoechst 33342 showed that the nuclei of untreated cells were uniformly stained
indicating unaltered nuclei (Fig. 1B, c), whereas
exposure to UVB resulted in nuclear condensation and fragmentation
(Fig. 1B, d). About 60-75% of the cells
underwent apoptosis 24 h after UVB irradiation. Furthermore, under
these conditions, less than 10% of the cells were stained with
propidium iodide or trypan blue (data not shown). Since these two dyes
label necrotic cells and, in some cases, cells at the late stages of
apoptosis, we can conclude that apoptosis was the predominant, if not
the only, type of cell death induced by 60 mJ/cm2 UVB.
The induction of apoptosis in UVB-treated cells was further
corroborated by the time-dependent activation of
pro-caspase-3 as determined by Western blot (Fig. 1C) and
DEVDase activity (see Fig.
2C). Pro-caspase-3 activation
became apparent at 16 h after irradiation and remained sustained
up to 24-30 h. Dose-response analysis indicated that the pro-caspase-3
activity was maximally induced at the UVB dose of 60 mJ/cm2
(data not shown). Correspondingly, the cleavage of PARP (Fig. 1D), a substrate of caspase-3 and -7, followed kinetics that
overlapped with those of the pro-caspase-3 processing and DEVD-amc
cleavage activity.
Molecular Mechanisms of UVB-induced Apoptosis: Cytochrome c Release
and the Cleavage of Bid--
To evaluate the contribution of the
mitochondrial pathway to the process of UVB-induced cell death, we
first analyzed the kinetics of cytochrome c release into the
cytosol of irradiated HaCaT cells. Fig. 2A shows that
cytosolic cytochrome c was detected 8 h after
irradiation and attained maximum levels in 24-30 h after UVB
treatment. In addition, Fig. 2B shows that, concomitant to the translocation of cytochrome c into the cytosol, the
processing of caspase-8 was also taking place, in agreement with
previous studies implicating this caspase activity in the process of
UV-induced apoptosis (4, 6, 8-10). These observations also indicate that the mitochondrial cytochrome c release and caspase-8
activation are among the earliest apoptotic events in the dying HaCaT
cells, clearly preceding the typical cell morphologic and nuclear
changes as well as the induction of DEVDase activity (Fig.
2C) and pro-caspase-3 processing (Fig. 1C).
Recent studies have shown that activated caspase-8 can mediate
mitochondrial cytochrome c release through the cleavage of the pro-apoptotic protein Bid (13). Therefore, we explored the possibility that the processing of Bid could be implicated in the
release of cytochrome c in our system as well. As shown in Fig. 2D, UVB irradiation of HaCaT cells caused a
time-dependent proteolysis of Bid. However, Bid processing
was a rather late event occurring significantly only 24 h after
irradiation. This suggests that Bid cleavage cannot be the cause of the
initial release of cytochrome c in UVB-treated HaCaT cells
but may represent a mechanism to maintain high level of cytosolic
cytochrome c in the dying cells. Furthermore, the initial
release of cytochrome c following UVB irradiation was not
significantly affected by caspase inhibitors (see Fig. 5E),
suggesting that, in irradiated cells, caspase-8 activation and
cytochrome c release are mediated by two independent pathways.
Role of the p38 MAPK and Caspase Signaling Cascades in the
UVB-induced Apoptosis--
To assess the role of the sustained
activation of p38 MAPK during UVB-induced apoptosis, we used its
specific pharmacological cell permeant inhibitor PD169316. This is a
powerful inhibitor of the p38 MAPK belonging to the class of
imidazole-based compounds used both in vivo and in
vitro to assess the specific involvement of the p38 MAPK pathway
in many physiological processes (22). Cell treatment with this drug
inhibited the myelin basic protein phosphotransferase activity of p38
MAPK in immunoprecipitation kinase assays without affecting the
activities of either JNK1 or ERK2 (data not shown). In addition, the
broad-spectrum caspase inhibitor zVAD-fmk and the inhibitor of
caspase-3-like caspases zDEVD-fmk were used to analyze the contribution
of the initiator (caspase-8) and/or effector (caspase-3) caspases,
respectively, in the process of UVB-induced apoptosis. Thus, HaCaT
cells were pretreated with zVAD-fmk, zDEVD-fmk, or different
concentrations of PD169316 before irradiation and the level of
apoptosis was analyzed 24 h after UVB treatment. Fig.
3 shows that all inhibitors could
counteract, albeit to different extents, the UVB-induced apoptosis.
Clearly, pretreatment with zVAD-fmk resulted in a superior protection
against apoptosis in comparison to zDEVD-fmk, in agreement with its
broad spectrum caspase inhibitory activity (23). The anti-apoptotic
effect of the PD169316 pretreatment was dose-dependent and
could be observed at concentrations as low as 2.5 µM. In
addition, pretreatment of the cells with the protein synthesis
inhibitor cycloheximide (100 µg/ml) prior to irradiation did not
result in a significant protection against UVB-induced apoptosis (data not shown), suggesting that newly synthesized proteins are likely not
required for this process.
In order to confirm that the observed anti-apoptotic activities of the
inhibitors were not due to a mere delay in the apoptotic process, we
looked into their long term effects on cell proliferation. Fig.
4 shows that, when pretreated with either
zVAD-fmk or PD169316, UVB-irradiated cells started to proliferate
following a brief cell cycle arrest. Fig. 4 also confirmed that
zVAD-fmk was the most effective inhibitor as the pretreated cells begun
to actively proliferate 24 h after irradiation and became nearly
confluent in 3 days. The combined pretreatment with zVAD-fmk and
PD169316 did not result in an additional protective effect when
compared with cells pretreated with zVAD-fmk alone.
We next analyzed the effects of these inhibitors at the biochemical
level. As shown in Fig. 5A,
both zVAD-fmk and zDEVD-fmk completely prevented the cleavage of PARP,
whereas pretreatment of cells with PD169316 significantly inhibited its
cleavage in a dose-dependent manner. As expected, both
caspase inhibitors, zVAD-fmk and zDEVD-fmk, completely obliterated the
DEVD-caspase activity in UVB-irradiated HaCaT cells (Fig.
5B). In agreement with the results of the PARP cleavage,
PD169316 also significantly inhibited the DEVDase activity (Fig.
5B). Western blot analysis revealed that the inhibitors
suppressed the cleavage of pro-caspase-3 as well (data not shown).
We were also interested in evaluating the effect of the inhibitors on
the UVB-induced cleavage of Bid. As shown in Fig. 5C, the
caspase inhibitor zVAD-fmk was the most efficient in counteracting Bid
degradation. The inhibition of DEVD-directed caspases only partially
reduced, while p38 MAPK inhibition did not affect Bid cleavage at all
(Fig. 5C). This observation suggests that the extrinsic,
death receptor-induced caspase-8 signaling pathway is likely to be the
most relevant mediator of Bid cleavage while the p38 MAPK pathway does
not contribute to this process. In addition, Fig. 5D
(left panel) shows that the UVB-induced
processing of pro-caspase-8 in HaCaT cells was not affected by PD169316
pretreatment and that, in turn, the caspase inhibitors did not
interfere with the p38 MAPK activation (Fig. 5D,
right panel). As suggested above, this result
indicates that UVB initiates multiple pathways independently.
Pretreatment of the cells with either zVAD-fmk or zDEVD-fmk had no
effect on the level of cytochrome c released 16 h after irradiation (Fig. 5E). This result implies that caspase
activity is not required for the early release of cytochrome
c following UVB treatment, in agreement with the results of
the delayed Bid cleavage (Fig. 2D). Importantly, cell
pretreatment with the p38 MAPK inhibitor PD169316 resulted in a
dose-dependent inhibition of the mitochondrial cytochrome
c efflux, when used in the concentration range of 2.5-25
µM. These concentrations of PD169316 were also shown to
severely inhibit downstream signaling events such as pro-caspase-3
activation and PARP cleavage (Fig. 5, A and B). Therefore, these results indicate that the p38 MAPK pathway is an
important mediator of the UVB-induced cytochrome c release from the mitochondria, the early phase of which appears to be independent of caspases.
Taken together, our overall observations strongly suggest that the p38
MAPK activation is positioned upstream of pro-caspase-3 activation and
functions as an important effector mechanism for the UVB-induced
apoptosis in human keratinocytes by facilitating the mitochondrial
efflux of cytochrome c.
In the present study, we show that exposure of human keratinocytes
to UVB induces the activation of p38 MAPK, cytochrome c release, pro-caspase-8 and -3 activation, Bid cleavage, and apoptosis. In agreement with recent reports (7, 19), exposure of HaCaT cells to
UVB led to a significant level of p38 MAPK activation in a dose- and
time-dependent manner. We have shown previously that
similar doses of UVB also lead to a robust activation of JNK1 (with
little effect on ERK2 activity) and a dramatic increase in the mRNA
expression of the immediate early genes c-jun and c-fos (15). These events are parts of the "UV response"
that is mediated by phosphorylation of preexisting transcription
factors c-Jun and/or c-Fos, resulting in the enhanced transcription of AP-1-responsive genes (3). Therefore, our results strongly implicate
the p38 MAPK as well as the JNK pathway in the transmission of the
UVB-induced stress responses in human keratinocytes.
A number of studies have reported on the role of JNK in coupling
cellular stress signals and specifically in the UV responses leading to
the apoptotic cell death (16-18). The role of ERK in protecting cells
against these types of stress-induced apoptotic processes has also been
reported recently (19). The functional role of p38 MAPK in cellular
stress response is, however, less well understood and rather
controversial. Some investigators have observed that p38 MAPK
activation in calphostin C-induced apoptosis of glioma cells requires
active caspases but is dispensable for cell death (24). Activation of
p38 MAPK in Fas-treated Jurkat cells has also been shown to be
dependent on the initiator caspases (25) but not on the executioner
caspases (26) and, in both cases, seemingly unrelated to the process of
apoptosis. Other reports have indicated that p38 MAPK activation occurs
either upstream or independent of caspases and mediates apoptosis
induced by various stresses (UVC, hyperosmolarity, sphingosine) in
human neutrophils (27). In contrast, p38 MAPK activation has been shown
to be protective against hypericin-induced apoptosis of HeLa cells
(20). In order to provide a possible role for the p38 MAPK activation
in UVB-irradiated HaCaT cells, we investigated its function in the
process of UVB-induced apoptosis.
In line with other reports (4-6), we present here strong evidence that
apoptosis induced by UVB is a typical caspase-dependent process and we implicate the extrinsic pathway of caspase activation as
an important component of the UVB-induced apoptotic process. Pretreatment of cells with the caspase inhibitors zVAD-fmk or zDEVD-fmk
drastically inhibited or reduced, respectively, the UVB-induced
apoptosis. In addition, the selective p38 MAPK inhibitor, PD169316,
substantially counteracted the induction of apoptosis in irradiated
HaCaT cells (Fig. 3). Both the caspase- and p38 MAPK inhibitors
considerably prevented the UVB-induced pro-caspase-3 processing and
activation (Fig. 5B) as well as PARP cleavage (Fig. 5A). On the other hand, neither one of the caspase
inhibitors had any effect on the activation of p38 MAPK (Fig.
5D, right panel), indicating that
divergent pathways are elicited by UVB irradiation and that the p38
MAPK functions upstream of pro-caspase-3 activation.
Our results show that cytochrome c release is one of the
earliest cellular responses to UVB irradiation (Fig. 2),
evidently preceding pro-caspase-3 activation and the onset of
apoptotic morphological changes. Interesting and novel
observations were made by analyzing the effect of the different
inhibitors on the release of mitochondrial cytochrome c. The
PD169316 pretreatment strongly counteracted the UVB-induced cytochrome
c release, whereas neither one of the caspase inhibitors
zVAD-fmk or zDEVD-fmk had any substantial effect on this process. This
suggests that the UVB-induced release of cytochrome c from
the mitochondria occurs independently of caspase activation and
requires p38 MAPK activity. Previous reports have also shown that
cytochrome c release induced by several apoptogenic stimuli,
including UV irradiation, staurosporine, and overexpression of Bax, is
independent of caspase activity (reviewed in Ref. 14) and precedes a
reduction in mitochondrial transmembrane potential (28). The
observation that zVAD-fmk, while inhibiting pro-caspase-3 activation
and apoptosis, does not prevent cytochrome c release,
implies that it targets key components of the intrinsic (downstream of
cytochrome c release) as well as the extrinsic pathway of
caspase activation. Bearing in mind the inhibitory effects of PD169316
on caspase-3 activation and PARP cleavage, our results strongly suggest
that this inhibitor acts by counteracting the mitochondrial cytochrome
c release. Hence, p38 MAPK mediates pro-caspase-3 activation
in UVB-irradiated cells by inducing the mitochondrial efflux of
cytochrome c through as yet an unknown mechanism.
Recent reports have shown that the p38 MAPK inhibitor SB203580, which
is structurally related to the PD169316, can trigger a significant,
Ras-independent activation of c-Raf in certain cell lines in the
concentration range of 8-25 µM (29, 30). Activated Raf
may phosphorylate and inactivate Bax, a pro-apoptotic member of the
Bcl-2 family of proteins, thereby preventing its cytochrome
c releasing activity. In our system, however, treatment of
HaCaT cells with PD169316 concentrations up to 25 µM,
either alone or in combination with UVB irradiation, did not induce any notable activation of c-Raf (data not shown). Moreover, as shown in
Fig. 5, mitochondrial cytochrome c efflux and the PARP
cleavage (data not shown) were considerably inhibited by PD169316
concentrations as low as 2.5 µM. Therefore, it is
unlikely that this indirect effect of the p38 MAPK inhibitor can
account for the prevention of cytochrome c release and
protection against apoptosis in UVB-treated HaCaT cells.
Recent reports have shown that, following UVC irradiation, p38 MAPK
phosphorylates the tumor suppressor protein p53 at different Ser
residues (31, 32) thereby increasing its transcriptional activity (31).
Given the evidence that the mutated p53 in HaCaT cells may still have a
role in apoptosis (33) and that it contains the p38 phosphorylation
sites (34), an interesting hypothesis could be that p38 MAPK mediates
mitochondrial cytochrome c release and apoptosis in a
p53-dependent fashion. The mechanisms by which p53 mediates
apoptosis are still unclear, and both
transcriptional-dependent and -independent pathways seem to
be involved (35, 36). In particular, a p53-mediated up-regulation of
the pro-apoptotic protein Bax (35) could explain how p38 MAPK induces
the release of cytochrome c from mitochondria of
UVB-irradiated cells. However, in our system, UVB did not lead to any
detectable transcriptional activation of Bax under apoptosis-inducing
conditions2 and the protein
synthesis inhibitor cycloheximide did not protect HaCaT cells from
apoptosis in agreement with previous findings (33). Thus, it seems that
the mechanism by which p38 MAPK induces mitochondrial cytochrome
c release and apoptosis in UVB-irradiated cells does not
require the de novo protein synthesis, whether or not it
involves p53 phosphorylation.
In some cellular systems, the cleavage of Bid, a proapoptotic Bcl-2
family member, results in the translocation of cytochrome c
from mitochondria to the cytoplasm (13). In UVB-treated cells, Bid
cleavage took place after 20-24 h of irradiation (Fig. 2) indicating
that it is not critical for the initial process of cell death. Whereas
the pretreatment of cells with zVAD-fmk, and to a lesser extent with
zDEVD-fmk, inhibited the UVB-induced Bid cleavage, PD169316 was without
any effect (Fig. 5C). Because PD169316 strongly inhibits
pro-caspase-3 activation but does not affect pro-caspase-8 cleavage,
this result suggests that caspase-8 is likely the main protease
responsible for Bid cleavage in UVB-treated cells. Why Bid should be
processed only at such a delayed time point is not clear. At most, Bid
cleavage at such late stage of apoptosis may provide a means of
maintaining high levels of cytosolic cytochrome c levels
that could augment the process of cell death.
Overall, our results provide new insights into the mechanisms involved
in the process of apoptosis induced by UVB in human keratinocytes and
identify a novel pathway mediated by the activation of p38 MAPK that
leads to the release of mitochondrial cytochrome c into the
cytosol, which significantly contributes to the induction of the
apoptotic process.
We thank G. Nijs for expert technical
assistance. We also thank Dr. N. E. Fusenig (German Cancer
Research Center, Division of Carcinogenesis and Differentiation,
Heidelberg, Germany) for kindly providing us with HaCaT cells.
*
This work was supported in part by Interuniversitaire
Attractiepolen Grant p4/26, Grant 0211.99 from the Fonds voor
Wetenschappelijk Onderzoek (FWO)-Vlaanderen, and European Biomed
Program Grant BMH4-CT96-0300.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
Recipient of a fellowship from the Vlaams Instituut voor de
Bevordering van het Wetenschappelijk-Technologisch Onderzoek in de Industrie.
**
Research leader with the FWO-Vlaanderen.
§§
To whom correspondence should be addressed. Tel.: 32-16-345-715;
Fax: 32-16-345-995; E-mail:
patricia.agostinis@med.kuleuven.ac.be.
Published, JBC Papers in Press, March 29, 2000, DOI 10.1074/jbc.M002634200
2
Z. Assefa, unpublished results.
The abbreviations used are:
TNF, tumor
necrosis-factor;
MAPK, mitogen-activated protein kinase;
ERK, extracellular signal-regulated protein kinase;
FADD, Fas-associated
death domain;
JNK, c-Jun N-terminal kinase;
PD169316, 4-(4-fluorophenyl)-2-(4-nitrophenyl)-5-(4-pyridyl)-1H-imidazole;
zDEVD-fmk, benzyloxycarbonyl-Asp-Glu-Val-Asp-fluoromethylketone;
zVAD-fmk, benzyloxycarbonyl-Val-Ala-Asp-fluoromethylketone;
PARP, poly(ADP-ribose)polymerase;
DEVD-amc, DEVD-amino-4-methylcoumarin;
DEVDase, DEVD-directed protease.
p38 Mitogen-activated Protein Kinase Regulates a Novel,
Caspase-independent Pathway for the Mitochondrial Cytochrome
c Release in Ultraviolet B Radiation-induced Apoptosis*
,
§,
,
**,

,
, and
**§§
Division of Biochemistry and
¶ Laboratory of Dermatology, Faculty of Medicine, Katholieke
Universiteit Leuven, Herestraat 49, B-3000 Leuven, Belgium and the
Department of Molecular Biology, Flanders Interuniversity
Institute for Biotechnology, University of Gent, Ledeganckstraat 35, B-9000 Gent, Belgium
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-32P]ATP was from Amersham Pharmacia Biotech,
while protein A-TSK was from Affiland (Liège, Belgium). zVAD-fmk
and zDEVD-fmk were purchased from Enzyme Systems Products (Livermore,
CA); DEVD-amc was from the Peptide Institute, Inc. (Osaka, Japan). The
p38 MAPK inhibitor PD169316 was purchased from Calbiochem (Bierges,
Belgium). Anti-p38 MAPK antibody and anti-phospho-p38 MAPK
(Thr180/Tyr182) monoclonal antibody, which
specifically recognizes the phosphorylated, active form of the kinase,
were purchased from New England Biolabs, Inc. (Beverly, MA). Mouse
anti-human PARP antibody was purchased from Biomol (Plymouth, PA),
caspase-3 antibody was from Santa Cruz (Santa Cruz, CA), caspase-8 and
cytochrome c antibodies were from PharMingen (San Diego,
CA), and Bid antibody was from R&D Systems (Minneapolis, MN).
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (63K):
[in a new window]
Fig. 1.
UVB induces p38 MAPK and apoptosis in HaCaT
cells. A, cells irradiated with a dose of 60 mJ/cm2 were harvested at the indicated time points, and the
phosphorylation of p38 MAPK was determined in total cell lysate as
described under "Experimental Procedures." Fold activation was
determined by densitometric scanning of the phospho-p38 MAPK bands on
the shown autoradiogram. B, phase-contrast (a and
b) and fluorescent (c and d)
microscopic images of untreated cells (a and c)
and cells treated with UVB (60 mJ/cm2) (b and
d) 24 h after irradiation. C and
D, time course of pro-caspase-3 and PARP cleavage in
UVB-irradiated cells (60 mJ/cm2).

View larger version (56K):
[in a new window]
Fig. 2.
Temporal relationship between
UVB-induced apoptotic events. Lysates of cells irradiated
with UVB (60 mJ/cm2) were harvested at the indicated time
points and subjected to Western blot analysis (A,
B, and D) using the respective antibodies as
indicated. C, DEVD-amc cleavage was measured as described
under "Experimental Procedures." Values indicated in A,
B, and D as arbitrary units were obtained by
densitometric scanning of the respective autoradiograms.

View larger version (31K):
[in a new window]
Fig. 3.
Effect of inhibitors on UVB-induced
apoptosis. Cells were left untreated or irradiated with 60 mJ/cm2 UVB in the presence or absence of the inhibitors as
indicated. The caspase inhibitors (100 µM each) were
added 2 h and PD169316 was added 1 h before irradiation.
20 h after irradiation, the number of cells with apoptotic
morphology was counted by microscopic examination. The percentage of
apoptotic cells relative to those in UVB-irradiated plate was
determined. The result shown is a representative of at least three
independent experiments.

View larger version (37K):
[in a new window]
Fig. 4.
Effect of UVB on cell proliferation in the
presence of PD169316 and zVAD-fmk. HaCaT cells were preincubated
with zVAD-fmk (100 µM), PD169316 (25 µM),
or their combination before exposure to 60 mJ/cm2 UVB. Cell
proliferation was determined at the indicated time periods as described
under "Experimental Procedures."

View larger version (33K):
[in a new window]
Fig. 5.
Effect of inhibitors on UVB-induced
responses. Lysates of untreated cells or cells irradiated in the
presence or in the absence of the inhibitors were prepared 16 h
after irradiation for the analysis of PARP cleavage (A),
DEVD-amc cleavage activity (B), pro-caspase-8 cleavage
(D, left panel), or cytochrome
c release (E); 24 h after irradiation for
Bid proteolysis (C) and at the indicated time points for p38
MAPK activation (D, right panel) as
described under "Experimental Procedures." In A,
C, D, and E, values shown as arbitrary
units were obtained by densitometric scanning of the respective
autoradiograms.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
ACKNOWLEDGEMENTS
![]()
FOOTNOTES

Research director with the FWO-Vlaanderen.
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1.
Longstreth, J.,
de Gruijl, F. R.,
Kripke, M. L.,
Abseck, S.,
Arnold, F.,
Slaper, H. I.,
Velders, G.,
Takizawa, Y.,
and van der Leun, J. C.
(1998)
J. Photochem. Photobiol. B.
46,
20-39
2.
Madronich, S.,
McKenzie, R. L.,
Bjorn, L. O.,
and Caldwell, M. M.
(1998)
J. Photochem. Photobiol. B.
46,
5-19
3.
Herrlich, P.,
Sachsenmaier, C.,
Radler-Pohl, A.,
Gebel, S.,
Blattner, C.,
and Rahmsdorf, H. J.
(1994)
Adv. Enzyme Regul.
34,
381-395
4.
Kulms, D.,
Poppelmann, B.,
Yarosh, D.,
Luger, T. A.,
Krutmann, J.,
and Schwarz, T.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
14,
7974-7979
5.
Takahashi, H.,
Kinouchi, M.,
and Iizuka, H.
(1997)
Biochem. Biophys. Res. Commun.
236,
194-198
6.
Aragane, Y.,
Kulms, D.,
Metze, D.,
Wilkes, G.,
Poppelmann, B.,
Luger, T. A.,
and Schwarz, T.
(1998)
J. Cell Biol.
140,
171-182
7.
Shimizu, H.,
Banno, Y.,
Sumi, N.,
Naganawa, T.,
Kitajima, Y.,
and Nozawa, Y.
(1999)
J. Invest. Dermatol.
112,
769-774
8.
Rosette, C.,
and Karin, M.
(1996)
Science
274,
1194-1197
9.
Leverkus, M.,
Yaar, M.,
and Gilchrest, B. A.
(1997)
Exp. Cell Res.
232,
255-262
10.
Rehemtulla, A.,
Hamilton, C. A.,
Chinnaiyan, A. M.,
and Dixit, V. M.
(1997)
J. Biol. Chem.
272,
25783-25786
11.
Ashkenazi, A.,
and Dixit, V. M.
(1998)
Science
281,
1305-1308
12.
Susin, S. A.,
Zamzami, N.,
and Kroemer, G.
(1998)
Biochim. Biophys. Acta
1366,
151-165
13.
Luo, X.,
Budihardjo, I.,
Zou, H.,
Slaughter, C.,
and Wang, X.
(1998)
Cell
94,
481-490
14.
Green, D. R.,
and Reed, J. C.
(1998)
Science
281,
1309-1312
15.
Assefa, Z.,
Garmyn, M.,
Bouillon, R.,
Merlevede, W.,
Vandenheede, J. R.,
and Agostinis, P.
(1997)
J. Invest. Dermatol.
108,
886-891
16.
Zanke, B. W.,
Boudreau, K,
Rubie, E.,
Winnett, E.,
Tibbles, L. A.,
Zon, L.,
Kyriakis, J.,
Liu, F. F.,
and Woodgett, J. R.
(1996)
Curr. Biol.
6,
606-613
17.
Chen, Y.-R.,
Wang, X.,
Templeton, D.,
Davis, R. J.,
and Tan, T.-H.
(1996)
J. Biol. Chem.
271,
31929-31936
18.
Butterfield, L.,
Storey, B.,
Maas, L.,
and Heasley, L. E.
(1997)
J. Biol. Chem.
272,
10110-10116
19.
Peus, D.,
Vasa, R. A.,
Beyerle, A.,
Meves, A.,
Krautmacher, C.,
and Pittelkow, M. R.
(1999)
J. Invest. Dermatol.
112,
751-756
20.
Assefa, Z.,
Vantieghem, A.,
Declercq, W.,
Vandenabeele, P.,
Vandenheede, J. R.,
Merlevede, W.,
de Witte, P.,
and Agostinis, P.
(1999)
J. Biol. Chem.
274,
8788-8796
21.
Palombella, V. J.,
and Vilcek, J.
(1989)
J. Biol. Chem.
264,
18128-18136
22.
Boehm, J. C.,
Smietana, J. M.,
Sorenson, M. E.,
Garigipati, R. S.,
Gallagher, T. F.,
Sheldrake, P. L.,
Bradbeer, J.,
Badger, A. M.,
Laydon, J. T.,
Lee, J. C.,
Hillegass, L. M.,
Griswold, D. E.,
Breton, J. J.,
Chabot-Fletcher, M. C.,
and Adams, J. L.
(1996)
J. Med. Chem.
39,
3929-3937
23.
Ekert, P. G.,
Silke, J.,
and Vaux, D. L.
(1999)
Cell Death Differ.
6,
1081-1086
24.
Ozaki, I.,
Tani, E.,
Ikemoto, H.,
Kitagawa, H.,
and Fujikawa, H.
(1999)
J. Biol. Chem.
274,
5310-5317
25.
Juo, P.,
Kuo, C. J.,
Reynolds, S. E.,
Konz, R. F.,
Raingeaud, J.,
Davis, R. J.,
Biemann, H. P.,
and Blenis, J.
(1997)
Mol. Cell. Biol.
17,
24-35
26.
Toyoshima, F.,
Moriguchi, T.,
and Nishida, E.
(1997)
J. Cell Biol.
139,
1005-1015
27.
Frasch, S. C.,
Nick, J. A.,
Fadok, V. A.,
Bratton, D. L.,
Worthen, G. S.,
and Henson, P. M.
(1998)
J. Biol. Chem.
273,
8389-8397
28.
Bossy-Wetzel, E.,
Newmeyer, D. D.,
and Green, D. R.
(1998)
EMBO J.
17,
37-49
29.
Hall-Jackson, C. A.,
Goedert, M.,
Hedge, P.,
and Cohen, P.
(1999)
Oncogene
18,
2047-2054
30.
Kalmes, A.,
Deou, J.,
Clowes, A. W.,
and Daum, G.
(1999)
FEBS Lett.
444,
71-74
31.
Huang, C.,
Ma, W. Y.,
Maxiner, A.,
Sun, Y.,
and Dong, Z.
(1999)
J. Biol. Chem.
274,
12229-12235
32.
Bulavin, D. V.,
Saito, S.,
Hollander, M. C.,
Sakaguchi, K.,
Anderson, C. W.,
Appella, E.,
and Fornace Jr, A. J.
(1999)
EMBO J.
18,
6845-6854
33.
Henseleit, U.,
Zhang, J.,
Wanner, R.,
Haase, I.,
Kolde, G.,
and Rosenbach, T.
(1997)
J. Invest. Dermatol.
109,
722-727
34.
Lehman, T. A.,
Modali, R.,
Boukamp, P.,
Stanek, J.,
Bennett, W. P.,
Welsh, J. A.,
Metcalf, R. A.,
Stampfer, M. R.,
Fusenig, N.,
Rogan, E. M.,
and Hurris, C. C.
(1993)
Carcinogenesis
14,
833-839
35.
Miyashita, T.,
and Reed, J. C.
(1995)
Cell
80,
293-299
36.
Caelles, C.,
Helmberg, A.,
and Karin, M.
(1994)
Nature
370,
220-223
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
S. A. Boswell, P. P. Ongusaha, P. Nghiem, and S. W. Lee The Protective Role of a Small GTPase RhoE against UVB-induced DNA Damage in Keratinocytes J. Biol. Chem., February 16, 2007; 282(7): 4850 - 4858. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hormi-Carver, L. A. Feagins, S. J. Spechler, and R. F. Souza All trans-retinoic acid induces apoptosis via p38 and caspase pathways in metaplastic Barrett's cells Am J Physiol Gastrointest Liver Physiol, January 1, 2007; 292(1): G18 - G27. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-H. Ahn, J. M. Jung, and S. H. Hong 8-Chloro-Cyclic AMP-Induced Growth Inhibition and Apoptosis Is Mediated by p38 Mitogen-Activated Protein Kinase Activation in HL60 Cells Cancer Res., June 1, 2005; 65(11): 4896 - 4901. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-C. Ma, H. Qian, F. Ghassemi, P. Zhao, and Y. Xia Oxygen-sensitive {delta}-Opioid Receptor-regulated Survival and Death Signals: NOVEL INSIGHTS INTO NEURONAL PRECONDITIONING AND PROTECTION J. Biol. Chem., April 22, 2005; 280(16): 16208 - 16218. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Li, Y. Xiao, and L. Zhang Cocaine Induces Apoptosis in Fetal Rat Myocardial Cells through the p38 Mitogen-Activated Protein Kinase and Mitochondrial/Cytochrome c Pathways J. Pharmacol. Exp. Ther., January 1, 2005; 312(1): 112 - 119. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Assefa, G. Bultynck, K. Szlufcik, N. Nadif Kasri, E. Vermassen, J. Goris, L. Missiaen, G. Callewaert, J. B. Parys, and H. De Smedt Caspase-3-induced Truncation of Type 1 Inositol Trisphosphate Receptor Accelerates Apoptotic Cell Death and Induces Inositol Trisphosphate-independent Calcium Release during Apoptosis J. Biol. Chem., October 8, 2004; 279(41): 43227 - 43236. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Mallikarjuna, S. Dhanalakshmi, R. P. Singh, C. Agarwal, and R. Agarwal Silibinin Protects against Photocarcinogenesis via Modulation of Cell Cycle Regulators, Mitogen-Activated Protein Kinases, and Akt Signaling Cancer Res., September 1, 2004; 64(17): 6349 - 6356. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Horn, A. Albor, Y. Liu, S. El-Hizawi, G. E. Vanderbeek, M. Babcock, G. T. Bowden, H. Hennings, G. Lozano, W. C. Weinberg, et al. RING protein Trim32 associated with skin carcinogenesis has anti-apoptotic and E3-ubiquitin ligase properties Carcinogenesis, February 1, 2004; 25(2): 157 - 167. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Sturniolo, S. R. Dashti, A. Deucher, E. A. Rorke, A.-M. Broome, R. A. S. Chandraratna, T. Keepers, and R. L. Eckert A Novel Tumor Suppressor Protein Promotes Keratinocyte Terminal Differentiation via Activation of Type I Transglutaminase J. Biol. Chem., November 28, 2003; 278(48): 48066 - 48073. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhang, M. I. Dawson, Y. Ning, L. Polin, R. E. Parchment, T. Corbett, A. N. Mohamed, K.-C. Feng, L. Farhana, A. K. Rishi, et al. Induction of apoptosis in retinoid-refractory acute myelogenous leukemia by a novel AHPN analog Blood, November 15, 2003; 102(10): 3743 - 3752. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Liao and M.-C. Hung Regulation of the Activity of p38 Mitogen-Activated Protein Kinase by Akt in Cancer and Adenoviral Protein E1A-Mediated Sensitization to Apoptosis Mol. Cell. Biol., October 1, 2003; 23(19): 6836 - 6848. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Pastorino, N. Shulga, and J. B. Hoek TNF-{alpha}-induced cell death in ethanol-exposed cells depends on p38 MAPK signaling but is independent of Bid and caspase-8 Am J Physiol Gastrointest Liver Physiol, August 8, 2003; 285(3): G503 - G516. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Weller, A. Schwentker, T. R. Billiar, and Y. Vodovotz Autologous nitric oxide protects mouse and human keratinocytes from ultraviolet B radiation-induced apoptosis Am J Physiol Cell Physiol, May 1, 2003; 284(5): C1140 - C1148. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-Y. He, J.-L. Huang, D. C. Ramirez, and C. F. Chignell Role of Reduced Glutathione Efflux in Apoptosis of Immortalized Human Keratinocytes Induced by UVA J. Biol. Chem., February 28, 2003; 278(10): 8058 - 8064. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Poulaki, C. S. Mitsiades, A. M. Joussen, A. Lappas, B. Kirchhof, and N. Mitsiades Constitutive Nuclear Factor-{kappa}B Activity Is Crucial for Human Retinoblastoma Cell Viability Am. J. Pathol., December 1, 2002; 161(6): 2229 - 2240. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Li and J. R. Bertino Fas-mediated Signaling Enhances Sensitivity of Human Soft Tissue Sarcoma Cells to Anticancer Drugs by Activation of p38 Kinase Mol. Cancer Ther., December 1, 2002; 1(14): 1343 - 1348. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Bowen, M. Birrer, and E. P. Gelmann Retinoblastoma Protein-mediated Apoptosis After gamma -Irradiation J. Biol. Chem., November 15, 2002; 277(47): 44969 - 44979. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. F. Holmes, D. R. Soprano, and K. J. Soprano Elucidation of Molecular Events Mediating Induction of Apoptosis by Synthetic Retinoids Using a CD437-resistant Ovarian Carcinoma Cell Line J. Biol. Chem., November 15, 2002; 277(47): 45408 - 45419. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Kuwabara, Y. Kuwabara, R.-Y. Yang, M. Schuler, D. R. Green, B. L. Zuraw, D. K. Hsu, and F.-T. Liu Galectin-7 (PIG1) Exhibits Pro-apoptotic Function through JNK Activation and Mitochondrial Cytochrome c Release J. Biol. Chem., January 25, 2002; 277(5): 3487 - 3497. [Abstract] [Full Text] [PDF] |
||||